Because Medicaid programs are so diverse from state to state, expansion may not cause such a radical departure from the current status, says Matt Salo, executive director of the National Association of Medicaid Directors.
Because Medicaid programs are so diverse from state to state, expansion may not cause such a radical departure from the current status, says Matt Salo, executive director of the National Association of Medicaid Directors.
Transcript (slightly modified)
What is the challenge of working with different states that may be in different stages of expanding Medicaid?
I think the irony is that it’s really no different than it has historically been. And one of the misperceptions about Medicaid is that it has always been one way, and then post-expansion it’s a different way. When in fact historically, since 1965, 50 state Medicaid programs have in fact looked quite different from one another.
While there’s a broad federal framework of who states must cover, what services they must provide, and basic parameters on how to structure and pay for things, there’s always been enormous state flexibility in moving around the edges and deciding, well who else do you want to cover? What other services do you want to provide? How do you want our organized care differently? Whether that’s managed care, whether that’s thinking about alternative approaches to nursing homes for people who need long-term care. Medicaid programs have traditionally looked very different from one another. Our job is to help each of them in whatever they’re doing, no matter how different they are.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More